Insight Molecular Diagnostics (IMDX) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 4.45% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 10.39% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 3.62% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 21.03% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -0.26% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 38.87% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -11.30% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 2.11% |
| 10 | Insight Molecular Diagnostics | 4.44 Mn | -24.49 Mn | 15,000.00 | 0.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25% |
| Dec 31, 2025 | -9.47% |
| Sep 30, 2025 | -23.48% |
| Jun 30, 2025 | -28.97% |
| Mar 31, 2025 | -24.60% |
| Dec 31, 2024 | -13.91% |
| Sep 30, 2024 | -22.95% |
| Jun 30, 2024 | -8.69% |
| Mar 31, 2024 | -21.40% |
| Dec 31, 2023 | -16.49% |
| Sep 30, 2023 | -10.35% |
| Jun 30, 2023 | 10.98% |
| Mar 31, 2023 | 14.21% |
| Dec 31, 2022 | 32.50% |
| Jun 30, 2022 | 203.76% |
| Mar 31, 2022 | 179.85% |
| Dec 31, 2021 | 108.81% |
| Sep 30, 2021 | 119.51% |
| Jun 30, 2021 | 92.63% |
| Mar 31, 2021 | 115.90% |